CSIMarket
 


Aclaris Therapeutics Inc   (ACRS)
Other Ticker:  
 

Aclaris Therapeutics Inc 's Leverage Ratio

ACRS's quarterly Leverage Ratio and Total Liabilities, Equity growth




ACRS Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change 1.5 % 0.83 % 60.47 % 424.15 % 431.4 %
Y / Y Total Liabilities Change 1.04 % -23.67 % -5.7 % 63.28 % 52.13 %
Leverage Ratio MRQ 0.21 0.17 0.26 0.27 0.21
Overall Ranking # # # # #
Seq. Equity Change -6.75 % 30.83 % -8.69 % -8.88 % -7.37 %
Seq. Total Liabilities Change 14.38 % -10.54 % -14.1 % 14.95 % -13.59 %



Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 14.38%, Leverage Ratio detoriated to 0.21, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Aclaris Therapeutics Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ACRS Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Aclaris Therapeutics Inc 's Equity $ 220 Millions Visit ACRS's Balance sheet
Aclaris Therapeutics Inc 's Total Liabilities $ 47 Millions Visit ACRS's Balance sheet
Source of ACRS's Sales Visit ACRS's Sales by Geography


Cumulative Aclaris Therapeutics Inc 's Leverage Ratio

ACRS's Leverage Ratio for the trailling 12 Months

ACRS Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth 1.5 % 0.83 % 60.47 % 424.15 % 431.4 %
Y / Y Total Liabilities TTM Growth 1.04 % -23.67 % -5.7 % 63.28 % 52.13 %
Leverage Ratio TTM 0.23 0.23 0.24 0.27 0.3
Total Ranking TTM # 531 # 618 # 636 # 778 # 714
Seq. Equity TTM Growth -6.75 % 30.83 % -8.69 % -8.88 % -7.37 %
Seq. Total Liabilities TTM Growth 14.38 % -10.54 % -14.1 % 14.95 % -13.59 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the net new borrowings of 14.38% Aclaris Therapeutics Inc managed to unchange Leverage Ratio in III. Quarter to 0.23, a new company low.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 178 other companies have achieved lower Leverage Ratio than Aclaris Therapeutics Inc . While Leverage Ratio total ranking has improved so far to 0, from total ranking in previous quarter at 580.

Explain Leverage Ratio?
Who are ACRS Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 179
Healthcare Sector # 301
Within the Market # 530


TTM Leverage Ratio Statistics
High Average Low
0.75 0.45 0.23
(Dec 31 2020)   (Jun 30 2022)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Acelrx Pharmaceuticals Inc  0.57 $ 15.432  Millions$ 27.226  Millions
Iterum Therapeutics Plc  0.56 $ 18.089  Millions$ 32.549  Millions
Marizyme Inc   0.55 $ 22.357  Millions$ 40.948  Millions
Medavail Holdings Inc   0.54 $ 16.807  Millions$ 31.306  Millions
Scpharmaceuticals Inc   0.53 $ 16.582  Millions$ 31.110  Millions
Vaxxinity Inc   0.53 $ 42.699  Millions$ 80.261  Millions
Aptinyx Inc   0.52 $ 25.193  Millions$ 48.792  Millions
Cyclerion Therapeutics Inc   0.52 $ 8.529  Millions$ 16.524  Millions
Aditxt Inc   0.51 $ 6.485  Millions$ 12.694  Millions
Cue Biopharma Inc   0.50 $ 25.536  Millions$ 50.764  Millions
Uniqure N v   0.50 $ 210.630  Millions$ 421.170  Millions
Cellectar Biosciences Inc   0.50 $ 6.367  Millions$ 12.751  Millions
Eyenovia inc   0.48 $ 9.692  Millions$ 20.329  Millions
Decibel Therapeutics Inc   0.47 $ 45.459  Millions$ 96.814  Millions
Metacrine Inc   0.46 $ 17.109  Millions$ 37.065  Millions
F star Therapeutics Inc   0.46 $ 25.953  Millions$ 56.938  Millions
Transcode Therapeutics Inc   0.45 $ 3.748  Millions$ 8.244  Millions
Beigene Ltd   0.44 $ 2,070.842  Millions$ 4,655.171  Millions
Amphastar Pharmaceuticals Inc   0.44 $ 221.530  Millions$ 505.165  Millions
Adial Pharmaceuticals Inc   0.43 $ 2.333  Millions$ 5.409  Millions
Nighthawk Biosciences inc   0.43 $ 35.699  Millions$ 83.126  Millions
Integrated Biopharma Inc  0.42 $ 7.743  Millions$ 18.621  Millions
Acadia Pharmaceuticals Inc   0.42 $ 176.805  Millions$ 425.686  Millions
Theriva Biologics inc   0.41 $ 22.552  Millions$ 55.415  Millions
Cyclacel Pharmaceuticals Inc   0.41 $ 8.954  Millions$ 22.067  Millions
Calithera Biosciences Inc   0.41 $ 10.695  Millions$ 26.388  Millions
Bicycle Therapeutics Plc  0.40 $ 116.677  Millions$ 289.474  Millions
Dermata Therapeutics Inc   0.40 $ 3.009  Millions$ 7.471  Millions
Arbutus Biopharma Corp  0.40 $ 58.284  Millions$ 145.517  Millions
Maia Biotechnology Inc   0.40 $ 4.913  Millions$ 12.326  Millions

Date modified: 2022-11-10T19:59:29+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FDC's Profile

Stock Price

FDC's Financials

Business Description

Fundamentals

Charts & Quotes

FDC's News

Suppliers

FDC's Competitors

Customers & Markets

Economic Indicators

FDC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071